Stock Market Winners & Losers: Stocks Fall as Higher Rates Creep Back In | Retail Sales Rose Stronger Than Expected in September | Should Insurance cover Ozempic, Weight Loss Drugs?

Loss: Stocks fall as higher rates creep back in
-Stocks slid, as rising bond yields once again weighed on investors and the third-quarter earnings season gained steam.
- The 10-year U.S. Treasury yield topped 4.80%,.
- Investors have also considered the potential impact from the Israel-Hamas war on the global economy.
Other Stories
- California taxpayers get until November 16 to file federal, state tax deadlines due to 2023 winter storms
- The price of Girl Scout cookies is going up. A boxes of Thin Mints and the rest that used to cost $5 will now sell for $6 in many areas.
- ATM fees are higher than ever for “Out-of-network” p $4.73 in fees, on average. Back in 1998 the average cash-machine customer paid $1.97. The average rose to $3.74 in 2010 and $4.52 in 2015.

Winner: Retail sales rose stronger than expected in September
- Consumers showed surprising strength in September despite high interest rates and worries over a weakening economy.
- Retail sales rose 0.7% on the month.
- Gas station sales were strong as prices at the pump accelerated.
- The numbers are not adjusted for inflation, so they indicate that consumers more than kept up with price increases.
- Sales gains were broad-based.
- Online sales rose 1.1%
- Motor vehicle parts and dealers saw a 1% increase
- Food services and drinking places grew by 0.9%, good for a yearly increase of 9.2%.
- Electronics sales fell and were one of the weak spots.
- Retail sales are the biggest part of our economy.

Winner: Should Insurance Cover Ozempic and Other New Weight-Loss Drugs?
- Weight loss drugs are the biggest disruptive technology I have ever seen.
- Insurance plans could cover blockbuster weight-loss medications?
- GLP-1 drugs Ozempic and Wegovy are popular for off-label use for weight loss on average of about 15% or more.
- GLP-1 is a hormone our bodies use the triggers the pancreas to produce insulin.
- These drugs are owned by Novo Nordisk.
- In America, 70% of people are obese or overweight.
- Obesity contributes to heart failure, breast cancer, colorectal cancer, prostate cancer, asthma, stroke, heart disease, Alzheimer's, chronic back pain, arthritis, diabetes, and hypertension.
- The direct and indirect costs of obesity total $1.7 trillion, or 7% of U.S. GDP.
- A 15% reduction in body weight would move 43 million Americans out of the obese column.
- Globally 800 million people, including 50 million children, are now obese.
- In July a bipartisan group of lawmakers reintroduced a bill to reauthorize Medicare coverage of weight-loss medications.

#RobBlackShow #RobBlack #Stocks #Viral #Trending #StockMarket #Stock #Market #Finance #Investing #Investment #MarketsUpdate #News
Learn More https://linktr.ee/RobBlack